Next-Generation Hair Growth Stimulation Platform
Legal Citation
Summary of the Inventive Concept
A futuristic, personalized hair growth stimulation system integrating advanced nanotechnology, wearable devices, and genetic profiling to revolutionize hair loss treatment and prevention.
Background and Problem Solved
The original patent for topical compositions of dutasteride addressed hair loss prevention and stimulation, but had limitations in terms of delivery, efficacy, and individualization. The new inventive concept overcomes these limitations by introducing a transdermal system, personalized treatment, and wearable devices for enhanced delivery and monitoring.
Detailed Description of the Inventive Concept
The next-generation hair growth stimulation platform comprises four key components: (1) a dutasteride-loaded nanoparticle formulation for transdermal delivery, (2) a genetic profiling system to determine individual susceptibility to hair loss, (3) a wearable, miniaturized device utilizing low-level laser therapy and/or electromagnetic stimulation to enhance delivery, and (4) a nanocarrier-based topical composition with targeting moieties for selective delivery to hair follicle stem cells. The platform also includes a wearable sensor for real-time hair growth monitoring, enabling personalized adjustments to treatment regimens.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in hair growth stimulation by integrating nanotechnology, wearable devices, and genetic profiling, providing a more effective, personalized, and convenient solution compared to the original patent's topical compositions.
Alternative Embodiments and Variations
Alternative embodiments of the platform could include variations in nanoparticle design, wearable device configurations, and genetic profiling methods. Additionally, the platform could be adapted for use with other hair growth stimulants or in combination with other hair loss treatments.
Potential Commercial Applications and Market
The next-generation hair growth stimulation platform has significant commercial potential in the cosmetic and pharmaceutical industries, targeting a growing market of individuals seeking effective and personalized hair loss solutions.
Original Patent Information
| Patent Number | US 11,857,556 |
|---|---|
| Title | Topical compositions of dutasteride |
| Assignee(s) | SHILPA MEDICARE LIMITED |